Berberine for High Cholesterol (Dyslipidemia)

Berberine is one of the few supplements with lipid effects large enough to show up reliably in meta-analysis. Pooled trials report LDL cholesterol reductions in the region of 20 to 25 mg/dL, with total cholesterol and triglycerides falling as well, alongside modest improvements in fasting glucose. It is best understood as a metabolic agent that happens to be sold as a supplement. That framing matters for two reasons: the effect is real, and so is the drug interaction profile, which is more significant than most people expect from a plant alkaloid. Berberine is not a statin substitute for anyone with established cardiovascular disease or very high LDL. Where it earns a place is in mixed dyslipidaemia with insulin resistance, in statin intolerance under medical supervision, or as an add-on when LDL remains above target.

Expect a lipid panel change rather than a felt effect. Recheck lipids after eight to twelve weeks of consistent dosing, because there is no symptom to track. Bioavailability is the practical limitation. Oral absorption is low single digits, which is why the dose is high and split across the day, and why gastrointestinal effects are the most common reason people stop.

Berberine lowers LDL by a route distinct from statins. It stabilises LDL receptor mRNA through an extracellular signal-regulated kinase pathway and upregulates receptor expression, increasing hepatic clearance of LDL particles without inhibiting HMG-CoA reductase. Because the mechanisms are complementary rather than overlapping, the effects can add to statin therapy. It also activates AMP-activated protein kinase, which suppresses lipogenesis and gluconeogenesis and improves insulin sensitivity, inhibits PCSK9 expression, and reduces intestinal cholesterol absorption. A meaningful part of its action is microbial: poorly absorbed berberine alters gut flora and bile acid signalling, and gut bacteria convert it to dihydroberberine, which is absorbed far more efficiently than the parent compound.

The trial-standard regimen is 500 mg of berberine hydrochloride two or three times daily, taken with meals, for a total of 1000 to 1500 mg per day. Splitting doses is not optional: single large doses cause cramping and diarrhoea without improving absorption. Start at 500 mg once daily for a week before building up, which substantially reduces gastrointestinal complaints. Dihydroberberine and phytosome formulations achieve similar exposure at lower milligram doses, so follow the label rather than scaling by weight.

A 2018 systematic review and meta-analysis of berberine for dyslipidaemia found significant reductions in total cholesterol, LDL and triglycerides across randomised trials, and a 2021 review of berberine monotherapy in metabolic disorders reported consistent lipid and glycaemic effects. An earlier 2004 randomised study in type 2 diabetes documented the lipid changes that prompted the field. The honest limitations: most trials are 8 to 16 weeks, sample sizes are small, the majority were conducted in Chinese populations with limited generalisability, product quality and alkaloid content vary between brands, and there are no cardiovascular outcome trials. Surrogate lipid improvements are not the same as proven event reduction.

Around a third of users report gastrointestinal effects: diarrhoea, constipation, cramping, bloating and a bitter taste. These are dose-dependent and largely avoidable with gradual titration and divided dosing with food. Two absolute cautions stand out. Berberine displaces bilirubin from albumin and must never be given to neonates or during pregnancy, because of kernicterus risk, and it should be avoided while breastfeeding. It also lowers blood glucose, so anyone on insulin or a sulfonylurea should monitor for hypoglycaemia. Reversible transaminase elevations have been reported occasionally, and continuous use beyond six months has not been well studied.

This is the part people underestimate. Berberine inhibits CYP3A4, CYP2D6 and CYP2C9 and inhibits P-glycoprotein, which puts it in the same interaction territory as grapefruit juice but with a wider reach. Review every prescription medication before starting it.